Article

Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively…

International Journal of Endocrinology · 2015 · Min Yi, author Rong-ping Chen, author Rui Yang, author Xian-feng Guo, author Jia-chun Zhang, author Hong Chen, author Youngah Jo, Academic Editor

Key facts

Title Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol
First author Min Yi, author Rong-ping Chen, author Rui Yang, author Xian-feng Guo, author Jia-chun Zhang, author Hong Chen, author Youngah Jo, Academic Editor
Journal International Journal of Endocrinology
Published Aug 24, 2015
DOI 10.1155/2015/479157
Devices mentioned K040471, K040692, K062862, K100010, K925155
Product codes mentioned CIT, JIT, KNK, LBS

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature